SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: Solid who wrote (7216)3/14/1999 11:36:00 AM
From: BigKNY3  Read Replies (1) | Respond to of 9523
 
The Big Pharma Report: 3/14/99

Have a PFun Sunday!

BigKNY3

________________________________________________________

Big Pharma Scoreboard 3/14/99

-Another big week for Big Pharma (+2.5%)...an all-time high adjusting for splits
-AMGN (+13.4%,+_43.5% YTD)...Wow!!!!
- AHP gained 9.9% based on lowered concerns about Redux' liability issues.
-PFE (+2.8%) finally broke the 140 level and continues to look strong.
-WLA jumped up 5.4% last week " 3/05/99 Big Pharma Report: WLA is a buy @68.83."

. Price % Chg % Chg % Chg
Rank . 03/12/99 Week March YTD 1999
1 Amgen 75.00 13.4% 20.1% 43.5%
2 Amer 65.38 9.9% 9.9% 16.0%
3 Merck 83.88 1.4% 2.9% 13.7%
4 Pfizer 140.38 2.8% 6.4% 12.3%
5 Lilly 94.88 -2.6% 0.4% 6.8%
6 J&J 88.56 -0.5% 3.7% 5.6%
7 Scher 58.00 1.8% 4.2% 5.0%
8 Abbott 49.81 0.8% 7.6% 1.7%
9 Smith 70.63 -0.4% -0.7% 1.6%
10 Pharma 57.00 5.8% 4.6% 0.7%
11 Warner 72.31 5.4% 5.1% -3.8%
12 Bristol 62.63 -4.0% -0.5% -6.4%
13 Glaxo 64.00 2.5% -0.1% -7.9%
Big Pharma 75.57 2.5% 4.7% 6.5%

Dow 9,897 1.7% 6.3% 7.8%
S&P 500 1,298 1.8% 4.8% 5.6%
NASDAQ 2,412 3.2% 5.4% 10.0%

News/chart/quote links to Big Pharma and ED stocks:

Yahoo! PFE News biz.yahoo.com

Five Day Chart of PFE versus the Dow quicken.com

A great PFE Stat Website dailystocks.com

Labpuppy.com Drug Stock Commentary (scroll down after opening) labpuppy.com

A New Investment Website Worth A Try
bridge.com


Big Pharma
Yahoo Link
quote.yahoo.com
Motley Fool Link
quote.fool.com

ED Stocks
Yahoo Link
quote.yahoo.com

Motley Fool Link
quote.fool.com

The 1999 Pharma Portfolio Challenge:

Motley Fool /SI Challenge Highlights

-Ron Flanagan (+22.9%) remains #1 with an equal trifecta of PFE/MRK/AMGN (Portfolio: 33% PFE/MRK/AMGN, 1% Cash).

-The 1998 PFEr of the Year Sinbadnaz (+20.8%) remains #2 (Portfolio: 50% MRK; 25% PFE/AMGN)

-The top 7 places have AMGN in their portfolios.

-The five 100% PFErs (+12.3%) dropped to 18th place (Portfolio: 100% PFE)

-Supporting the principles behind the Peabody Model: PEABODY PURCHASE (+4.8%) is beating PFE DRIP (+1.8%). Both portfolios are weighed down due to their large cash accounts in the growing Big Pharma market.

-SHORT COX II (-13.0%) is deeper in the cellar (Portfolio: 50% short PFE; 50% short MRK)

-SHORT PFE (-12.3%) remains in 64th place (Portfolio: 100% short PFE)

-PFE DRIP SHORT (-0.0%) is now in the red (Portfolio: 84% in cash, 16% in shorting PFE at monthly DRIP prices)

Click here for a breakdown of the holdings of the 64 Challenge portfolios
www3.techstocks.com